Remove Clinical Research Remove Drug Trials Remove Pharma Companies Remove Research
article thumbnail

How using AI in clinical trials accelerates drug development

Pharmaceutical Technology

Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. Food and Drug Administration approval.

article thumbnail

Bayer-led project on AI in trials eyes ‘virtual’ placebo groups

pharmaphorum

” Conducting this kind of research in Finland makes sense, as it has a sophisticated healthcare system but a small population, which can make it challenging to carry out clinical research using traditional approaches. . “On the other hand, [they] should be able to tell a user if they are no longer reliable.”

Trials 69